Functional study of novel PAX9 variants: The paired domain and non‐syndromic oligodontia

Objectives To investigate pathogenic variants of the paired box 9 (PAX9) gene in patients with non‐syndromic oligodontia, and the functional impact of these variants. Subjects and Methods Whole exome sequencing and Sanger sequencing were utilized to detect gene variants in a cohort of 80 patients di...

Full description

Saved in:
Bibliographic Details
Published in:Oral diseases Vol. 27; no. 6; pp. 1468 - 1477
Main Authors: Sun, Kai, Yu, Miao, Yeh, Iting, Zhang, Liutao, Liu, Haochen, Cai, Tao, Feng, Hailan, Liu, Yang, Han, Dong
Format: Journal Article
Language:English
Published: Denmark Wiley Subscription Services, Inc 01-09-2021
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Objectives To investigate pathogenic variants of the paired box 9 (PAX9) gene in patients with non‐syndromic oligodontia, and the functional impact of these variants. Subjects and Methods Whole exome sequencing and Sanger sequencing were utilized to detect gene variants in a cohort of 80 patients diagnosed with non‐syndromic oligodontia. Bioinformatic and conformational analyses, fluorescence microscopy and luciferase reporter assay were employed to explore the functional impact. Results We identified three novel variants in the PAX9, including two frameshift variants (c.211_212insA; p.I71Nfs*246 and c.236_237insAC; p.T80Lfs*6), and one missense variant (c.229C > G; p.R77G). Familial co‐segregation verified an autosomal‐dominant inheritance pattern. Conformational analyses revealed that the variants resided in the paired domain, and could cause corresponding structural impairment of the PAX9 protein. Fluorescence microscopy showed abnormal subcellular localizations of frameshift variants, and luciferase assay showed impaired downstream transactivation activities of the bone morphogenetic protein 4 (BMP4) gene in all variants. Conclusions Our findings broaden the spectrum of PAX9 variants in patients with non‐syndromic oligodontia and support that paired domain structural impairment and the dominant‐negative effect are likely the underlying mechanisms of PAX9‐related non‐syndromic oligodontia. Our findings will facilitate genetic diagnosis and counselling, and help lay the foundation for precise oral health therapies.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1354-523X
1601-0825
DOI:10.1111/odi.13684